1nhaler Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.93M

  • Investors
  • 4

1nhaler General Information

Description

Developer of a dry powder inhaler designed to assist with inhalable medications. The company offers a breath-activated, low-cost disposable cardboard device that uses a breathable membrane to store the relevant drug within the device to avoid the issue of agglomeration and provide convenient single-dose inhalers, enabling customers to replace traditional inhalers with portable, distributable, and recyclable alternatives and access life-saving inhalable drugs.

Contact Information

Website
www.1nhaler.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 Lothian Road, Festival Square
  • Edinburgh EH3 9WJ
  • Scotland, United Kingdom
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • 50 Lothian Road, Festival Square
  • Edinburgh EH3 9WJ
  • Scotland, United Kingdom

1nhaler Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

1nhaler Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 03-Nov-2026 $4.93M Completed Pre-Clinical Trials
3. Later Stage VC 27-Nov-2023 Completed Pre-Clinical Trials
2. Grant 01-Nov-2023 $931K $131K Completed Startup
1. Angel (individual) 13-Apr-2019 $131K $131K Completed Startup
To view 1nhaler’s complete valuation and funding history, request access »

1nhaler Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
Ordinary Shares
Ordinary Shares
Ordinary Shares
Ordinary Shares 29,400 $0.000133 $3.4 $3.4 1x $3.4 1.35%
Ordinary Shares 143,000 $0.000133 $0.93 $0.93 1x $0.93 6.59%
To view 1nhaler’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

1nhaler Patents

  • 37

    Total Documents Applications and Grants

  • Total Patents Families

  • 28

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

1nhaler Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202212133-D0 Inhaler Inactive 19-Aug-2022
AU-2023217295-A1 Inhaler Pending 08-Feb-2022
EP-4475919-A1 Inhaler Active 08-Feb-2022
EP-4475919-B1 Inhaler Active 08-Feb-2022
EP-4475919-C0 Inhaler Active 08-Feb-2022 A61M15/0001
To view 1nhaler’s complete patent history, request access »

1nhaler Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

1nhaler Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Archangel Investors Angel Group Minority
British Business Investments Fund of Funds Minority
Angel (individual) Minority
Scottish Enterprise Growth/Expansion Minority
To view 1nhaler’s complete investors history, request access »

Ready to get started?

Request a free trial

1nhaler FAQs

  • When was 1nhaler founded?

    1nhaler was founded in 2017.

  • Where is 1nhaler headquartered?

    1nhaler is headquartered in Edinburgh, United Kingdom.

  • What is the size of 1nhaler?

    1nhaler has 6 total employees.

  • What industry is 1nhaler in?

    1nhaler’s primary industry is Therapeutic Devices.

  • Is 1nhaler a private or public company?

    1nhaler is a Private company.

  • What is the current valuation of 1nhaler?

    The current valuation of 1nhaler is .

  • What is 1nhaler’s current revenue?

    The current revenue for 1nhaler is .

  • How much funding has 1nhaler raised over time?

    1nhaler has raised $7.53M.

  • Who are 1nhaler’s investors?

    Archangel Investors, British Business Investments, , and Scottish Enterprise have invested in 1nhaler.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process